Compounds > azacitidine

azacitidine and Carcinoma, Small Cell

azacitidine has been researched along with Carcinoma, Small Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brambilla, E; Gazdar, AF; Minna, JD; Padar, A; Sathyanarayana, UG; Takahashi, T; Toyooka, S1
Fujisawa, T; Gazdar, AF; Iizasa, T; Sathyanarayana, UG; Shigematsu, H; Shivapurkar, N; Suzuki, M; Takahashi, T1
Fujisawa, T; Gazdar, AF; Iizasa, T; Minna, JD; Shames, DS; Shigematsu, H; Shivapurkar, N; Sunaga, N; Suzuki, M; Takahashi, T1
Chahinian, AP; Greenfield, DS; Holland, JF; Ohnuma, T1
Behnke, O; Olsson, L; Sørensen, HR1

Other Studies

5 other study(ies) available for azacitidine and Carcinoma, Small Cell

ArticleYear
Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:7

    Topics: Azacitidine; Carcinoid Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Adhesion Molecules; Cell Line, Tumor; CpG Islands; Decitabine; DNA; DNA Methylation; Humans; Kalinin; Laminin; Lung Neoplasms; Lymphocytes; Methylation; Models, Genetic; Mouth Mucosa; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sulfites; Transcription, Genetic; Tumor Cells, Cultured

2003
Aberrant methylation of Reprimo in lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2005, Volume: 47, Issue:3

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Cycle; Cell Cycle Proteins; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Genes, p53; Glycoproteins; Humans; Lung Neoplasms; Lymphocytes; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured

2005
Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Annals of surgical oncology, 2007, Volume: 14, Issue:4

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; CpG Islands; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Lung Neoplasms; Male; Middle Aged; Promoter Regions, Genetic; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured

2007
Sequential combination of pyrazofurin and 5-azacytidine in patients with acute myelocytic leukemia and carcinoma.
    Oncology, 1981, Volume: 38, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Amides; Azacitidine; Carcinoma; Carcinoma, Small Cell; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Lung Neoplasms; Male; Middle Aged; Pyrazoles; Ribonucleosides; Ribose

1981
Modulatory effects of 5-azacytidine, phorbol ester, and retinoic acid on the malignant phenotype of human lung cancer cells.
    International journal of cancer, 1985, Feb-15, Volume: 35, Issue:2

    Topics: Animals; Azacitidine; Carcinoma, Small Cell; Cell Line; Clone Cells; Humans; Lung Neoplasms; Mice; Mice, Nude; Mitosis; Neoplasm Transplantation; Phenotype; Phorbols; Tetradecanoylphorbol Acetate; Tretinoin

1985